Discovering new and better treatments
We’re partnering with Internationally renowned scientists and academics to validate the promise of our drug candidates as anti-inflammatory and anti-ageing technologies that treat the causes of disease and decline rather than simply focusing on the symptoms. MyMD is working to rapidly advance MYMD-1® and Supera-CBD in clinical trials while identifying and validating additional novel targets.
See the Research